State Street’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.87M | Buy |
456,927
+9,860
| +2% | +$182K | ﹤0.01% | 2626 |
|
|
2025
Q4 | $6.14M | Buy |
447,067
+25,187
| +6% | +$392K | ﹤0.01% | 2892 |
|
|
2025
Q3 | $7.47M | Buy |
421,880
+2,624
| +0.6% | +$41.5K | ﹤0.01% | 2801 |
|
|
2025
Q2 | $6.33M | Buy |
419,256
+12
| +0% | +$199 | ﹤0.01% | 2834 |
|
|
2025
Q1 | $6.75M | Sell |
419,244
-55,006
| -12% | -$1.03M | ﹤0.01% | 2755 |
|
|
2024
Q4 | $8.26M | Buy |
474,250
+12,917
| +3% | +$228K | ﹤0.01% | 2737 |
|
|
2024
Q3 | $8.09M | Buy |
461,333
+69,696
| +18% | +$1.19M | ﹤0.01% | 2730 |
|
|
2024
Q2 | $4.38M | Buy |
391,637
+41,897
| +12% | +$395K | ﹤0.01% | 2981 |
|
|
2024
Q1 | $3.05M | Buy |
349,740
+40,220
| +13% | +$370K | ﹤0.01% | 3127 |
|
|
2023
Q4 | $3.79M | Buy |
309,520
+25,284
| +9% | +$175K | ﹤0.01% | 3076 |
|
|
2023
Q3 | $1.15M | Sell |
284,236
-399
| -0.1% | -$2.48K | ﹤0.01% | 3492 |
|
|
2023
Q2 | $2.05M | Buy |
284,635
+216,534
| +318% | +$1.38M | ﹤0.01% | 3403 |
|
|
2023
Q1 | $229K | Hold |
68,101
| – | – | ﹤0.01% | 4037 |
|
|
2022
Q4 | $189K | Buy |
68,101
+17,400
| +34% | +$39.1K | ﹤0.01% | 4126 |
|
|
2022
Q3 | $117K | Hold |
50,701
| – | – | ﹤0.01% | 4403 |
|
|
2022
Q2 | $78K | Sell |
50,701
-193,524
| -79% | -$487K | ﹤0.01% | 4614 |
|
|
2022
Q1 | $1.19M | Buy |
244,225
+2,310
| +1% | +$18.9K | ﹤0.01% | 3754 |
|
|
2021
Q4 | $3.58M | Sell |
241,915
-1,811
| -0.7% | -$36.1K | ﹤0.01% | 3401 |
|
|
2021
Q3 | $5.26M | Buy |
243,726
+107
| +0% | +$2.3K | ﹤0.01% | 3209 |
|
|
2021
Q2 | $4M | Buy |
243,619
+14,050
| +6% | +$267K | ﹤0.01% | 3347 |
|
|
2021
Q1 | $5.44M | Sell |
229,569
-399
| -0.2% | -$11.9K | ﹤0.01% | 3015 |
|
|
2020
Q4 | $5.49M | Buy |
229,968
+307
| +0.1% | +$4.88K | ﹤0.01% | 2915 |
|
|
2020
Q3 | $2.71M | Sell |
229,661
-1,675
| -0.7% | -$18K | ﹤0.01% | 3076 |
|
|
2020
Q2 | $2.42M | Buy |
231,336
+41,522
| +22% | +$374K | ﹤0.01% | 3102 |
|
|
2020
Q1 | $1.36M | Sell |
189,814
-630
| -0.3% | -$6.54K | ﹤0.01% | 3226 |
|
|
2019
Q4 | $2.55M | Buy |
190,444
+7,153
| +4% | +$102K | ﹤0.01% | 3159 |
|
|
2019
Q3 | $2.83M | Buy |
183,291
+19,240
| +12% | +$250K | ﹤0.01% | 3087 |
|
|
2019
Q2 | $2.17M | Buy |
164,051
+9,094
| +6% | +$124K | ﹤0.01% | 3208 |
|
|
2019
Q1 | $2.73M | Buy |
154,957
+12,721
| +9% | +$200K | ﹤0.01% | 3038 |
|
|
2018
Q4 | $1.63M | Sell |
142,236
-5,918
| -4% | -$71.6K | ﹤0.01% | 3195 |
|
|
2018
Q3 | $2.1M | Buy |
148,154
+15,462
| +12% | +$220K | ﹤0.01% | 3225 |
|
|
2018
Q2 | $2.01M | Sell |
132,692
-2,424
| -2% | -$41K | ﹤0.01% | 3254 |
|
|
2018
Q1 | $1.83M | Sell |
135,116
-3,038
| -2% | -$57.7K | ﹤0.01% | 3205 |
|
|
2017
Q4 | $3.26M | Sell |
138,154
-548
| -0.4% | -$12.9K | ﹤0.01% | 2984 |
|
|
2017
Q3 | $2.58M | Buy |
138,702
+7,265
| +6% | +$165K | ﹤0.01% | 3093 |
|
|
2017
Q2 | $4.54M | Buy |
+131,437
| New | +$3.61M | ﹤0.01% | 2786 |
|
Other funds holding PLSE
VCM
PCM
GAM
LP
State Street's PLSE Position: Q1 2026 in Review
State Street increased its Pulse Biosciences (PLSE) stake by 2.2% in Q1 2026, buying an estimated $182K and bringing the position to 456,927 shares worth $9.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2626.
State Street first reported a position in PLSE in Q2 2017 and has held it in 36 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.
- State Street held 456,927 shares of Pulse Biosciences worth $9.87M as of Q1 2026.
- State Street bought 9,860 Pulse Biosciences shares in Q1 2026, an estimated $182K.
- Pulse Biosciences made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2626 holding.
- State Street first reported a position in Pulse Biosciences in Q2 2017 and has held it in 36 quarters since.
- 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.